Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Number/quality of endoscopic biopsy samples in gastrointestinal cancers for biomarker testing: All that glitters is not gold

作者:Federica Grillo, Alessandro Gambella, Silvia Bozzano, Michele Paudice, Nataniele Piol, Manuele Furnari, Stefania Sciallero, Alessandro Pastorino, Anna Pessino, Paola Parente, Alessandro Vanoli, Matteo Fassan, Luca Mastracci · 发表于:Digestive and Liver Disease · 年份:2025 · DOI:10.1016/j.dld.2025.12.005 · 被引用次数:2 · 研究领域:Cancer Genomics and Diagnostics、Esophageal Cancer Research and Treatment、Gastric Cancer Management and Outcomes

BACKGROUND: Management of gastrointestinal (GI) cancers has shifted from conventional chemotherapy to biomarker-based precision oncology. Biomarker assessment requires adequate endoscopic biopsy tissue both in gastro-esophageal/gastric and colorectal carcinomas. AIMS: This study evaluated real-world endoscopic biopsy adequacy, focusing on tissue quality and suitability for biomarker analysis. METHODS: We retrospectively reviewed 819 endoscopic procedures (274 upper-GI and 545 lower-GI; time-window: January 2021-2024). Gastrointestinal pathologists reviewed 4,908 biopsies to assess diagnostic yield, number of invasive carcinoma-containing biopsies, and tumor cellularity. Biopsy adequacy was evaluated against European Society of Gastrointestinal Endoscopy (ESGE) recommendations and biomarker-specific cellularity thresholds. RESULTS: A histologic diagnosis of invasive carcinoma was established in 96 % of upper-GI and 84 % of lower-GI procedures (p<0.001). However, 41-43 % of procedures yielded fewer than six biopsies, which is below ESGE guidance. Importantly, only 66.7 % of upper-GI and 49.7 % of lower-GI biopsies contained invasive carcinoma, while the rest were composed of samples inadequate for biomarker testing (such as non-invasive lesions, mucin, necrosis, granulation tissue, and normal mucosa). Low neoplastic cellularity (<1000 tumor cells) was observed in 27 % of upper-GI and 5 % of lower-GI cases, while <20 % tumor cellularity was present in 41.7 % of colorectal biopsi...